Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...
Hlavní autoři: | Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Cell Press
2020
|
Podobné jednotky
-
Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
Autor: Daniel Wright, a další
Vydáno: (2020-11-01) -
Rift Valley fever: biology and epidemiology
Autor: Wright, D, a další
Vydáno: (2019) -
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
Autor: Huiskonen, J, a další
Vydáno: (2009) -
Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
Autor: Benjamin Gutjahr, a další
Vydáno: (2020-03-01) -
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
Autor: Paul J. Wichgers Schreur, a další
Vydáno: (2021-03-01)